Back to companies

Johnson & Johnson (J&J) researches, develops, manufactures, and sells pharmaceutical products, medical devices, and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious, cardiovascular and metabolic diseases; consumer products in oral care, baby care, beauty, over-the-counter (OTC) medicines, women’s health and wound care categories; and medical devices for use in the cardiovascular, orthopaedic, general surgery and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, health care professionals and hospitals; and offers consumer products through retail outlets and distributors. The company offers its products in the US; Europe; Asia-Pacific and Africa; and Western Hemisphere (excluding the US). J&J is headquartered in New Brunswick, New Jersey, the US.

Headquarters United States of America

Address One Johnson & Johnson Plaza, New Brunswick, New Jersey, 08933


Telephone 1 732 5242455

No of Employees 141,700

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange JNJ (NYSE)

Revenue (2020) $93.8B 13.6% (2020 vs 2019)

EPS XXX

Net Income (2020) XXX 41.9% (2020 vs 2019)

Market Cap* $432.6B

Net Profit Margin (2020) XXX 24.9% (2020 vs 2019)

* As of and is in US$

Access premium data and analytics for Johnson & Johnson

4,100+

Clinical Trials

Determine Johnson & Johnson go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

1,400+

Catalyst Calendar

Proactively evaluate Johnson & Johnson’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1,100+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Johnson & Johnson’s relevant decision makers and contact details.

750+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

650+

Pipeline Drugs

Identify which of Johnson & Johnson’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

370+

Marketed Drugs

Understand Johnson & Johnson’s commercialized product portfolio to stay one step ahead of the market.

100+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

60+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Johnson & Johnson and assess market opportunity for new entrants with patient population 8-year forecasts.

5

Investigators

Review investigator profiles and find information on trial contacts across Johnson & Johnson, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

4,700+

Consumer Market Data Insights

Gain insights from product sales across markets, product categories and channels. Get intelligence on market shares, retail sales footprint, market position and strength for consumer segments and geographies.

1,600+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

1,200+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

780+

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

150+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

9

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Johnson & Johnson (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Johnson & Johnson’s likely spend across technology areas enabling you to understand the digital strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Pharmaceutical JOHNSON’S
Immunology: LISTERINE
Rheumatoid Arthritis AVEENO
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Spin-off In September, the company announced to spin off its consumer health business and new company to be called Kenvue.
2022 Contracts/Agreements In September, Johnson & Johnson Philippines and aCommerce Group partnered to offer a sustainable packaging alternative and 100% recyclable solution in the Philippines.
2022 Corporate Changes/Expansions In September, the company opened its San Francisco Bay Campus, a state-of-the-art Research & Development facility in San Francisco Bay Area.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Johnson & Johnson Pfizer Inc F. Hoffmann-La Roche Ltd Novartis AG Merck & Co Inc
Headquarters United States of America United States of America Switzerland Switzerland United States of America
City New Brunswick New York Basel Basel Kenilworth
State/Province New Jersey New York - - New Jersey
No. of Employees 141,700 79,000 100,920 108,000 68,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Alex Gorsky Chairman Executive Board 2022 61
Joaquin Duato Director; Chief Executive Officer Executive Board 2022 59
James Swanson Director; Chief Information Officer; Executive Vice President Executive Board 2021 56
William N. Hait, M.D., Ph. D. Executive Vice President; Chief External Innovation, Medical Safety and Global Public Health Officer; Director Executive Board 2022 72
Kurt Van den Bosch Chief Financial Officer Senior Management 2022 -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer